HBOC Awareness Week, National Previvor Day

September 26, 2012 is National Previvor Day. At Myriad, we believe knowledge is power, and Previvors embody this sentiment. A Previvor refers to an individual who carries a strong predisposition to cancer but has not developed cancer. These individuals proactively sought out knowledge to determine if they inherited a gene mutation by having genetic testing performed. The results of this testing subsequently allow them to make informed medical decisions to reduce their cancer risk.

Knowing about an inherited mutation gives you power to take steps that may help reduce your risk for cancer, or detect cancer at an earlier and more treatable stage. Breast and ovarian cancer risk can be greatly reduced through increased monitoring, preventive drug treatment, or preventive surgery.

Check out Jodi’s video and listen to her story on being a Previvor

Talk with your healthcare professional about hereditary cancer risk assessment and testing.

-Sarah Watts, Oncology Marketing

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.